In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.
|Podcasts|March 17, 2023
Using Pharmacovigilance Platforms to One’s Advantage
Author(s)Nicholas Saraceno, Senior Editor
How these applications—combined with artificial intelligence, machine learning, and natural language processing—influence workflows.
Advertisement
Updesh Dosanjh, practice leader for the pharmacovigilance (PV) technology solutions business unit at IQVIA, discusses the ways in which PV platforms decrease the time, expense, and risk involved in manual reporting, along with how technologies are impacting these types of workloads.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
In this week's Pharma Pulse, DHL adds six dedicated cold chain air corridors linking Europe and North America to Asia, Walmart rolls out a $0 prescription tier and rare disease Center of Excellence for its US workforce and FDA launches its Rare Disease Framework Initiative.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Is Pharma Moving Too Fast on AI Agents?
2
Walgreens Expands GLP-1 Access With Prior Authorization, Pharmacist Support
3
How Autonomous AI Is Reshaping Biopharma Operations
4
Freehand CEO: AI Is Here and Now in Supply Chains
5